α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease
- PMID: 20816781
- DOI: 10.1016/j.nbd.2010.08.022
α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease
Abstract
α-Synuclein is an abundant neuronal protein that has been linked to both normal synaptic function and neurodegenerative disease, in particular, Parkinson's disease (PD). Evidence from both in vitro and in vivo studies indicate that increased wild type or mutant α-synuclein can cause PD, but the molecular mechanisms that underlie α-synuclein-mediated neurotoxicity remain poorly understood. We reported here that myocyte enhancer factor 2D (MEF2D), a nuclear transcription factor known to promote neuronal survival, is down regulated in response α-synuclein accumulation and aggregation. Our data demonstrated that levels of cytoplasmic and nuclear MEF2D were significantly decreased in PD nigral neurons when compared to the nigra of age-matched controls and Alzheimer's disease (AD) cases. This decrease was significantly greater in the nigral neurons with α-synuclein inclusions. Viral vector-mediated overexpression of human α-synuclein in rats resulted in significantly decreased MEF2D in nigral neurons similar to what was seen in PD. The decline of MEF2D-immunoreactivity was associated with a reduction in TH-immunoreactivity. These results indicate that the neuronal survival factor MEF2D is decreased in human and experimental PD, and this decrease is specifically associated with α-synuclein accumulation and aggregation.
Copyright © 2010. Published by Elsevier Inc.
Similar articles
-
Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.Neurobiol Dis. 2009 Sep;35(3):385-98. doi: 10.1016/j.nbd.2009.05.023. Epub 2009 Jun 6. Neurobiol Dis. 2009. PMID: 19505575
-
Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.Acta Neuropathol. 2003 Sep;106(3):191-201. doi: 10.1007/s00401-003-0725-y. Epub 2003 Jul 5. Acta Neuropathol. 2003. PMID: 12845452
-
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x. J Neurochem. 2004. PMID: 15447678
-
Synucleins and their relationship to Parkinson's disease.Cell Tissue Res. 2004 Oct;318(1):163-74. doi: 10.1007/s00441-004-0921-7. Epub 2004 Jul 24. Cell Tissue Res. 2004. PMID: 15503152 Review.
-
Alpha-synuclein and Parkinson's disease: a proteomic view.Expert Rev Proteomics. 2008 Apr;5(2):239-48. doi: 10.1586/14789450.5.2.239. Expert Rev Proteomics. 2008. PMID: 18466054 Review.
Cited by
-
Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.J Biol Chem. 2012 Oct 5;287(41):34246-55. doi: 10.1074/jbc.M112.367540. Epub 2012 Aug 13. J Biol Chem. 2012. PMID: 22891246 Free PMC article.
-
Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson's Disease.Front Mol Neurosci. 2016 Dec 23;9:157. doi: 10.3389/fnmol.2016.00157. eCollection 2016. Front Mol Neurosci. 2016. PMID: 28066181 Free PMC article. Review.
-
Aberrant autophagy and parkinsonism: does correction rescue from disease progression?Mol Neurobiol. 2015;51(3):893-908. doi: 10.1007/s12035-014-8744-3. Epub 2014 May 16. Mol Neurobiol. 2015. PMID: 24833602 Review.
-
MiR-421 Aggravates Neurotoxicity and Promotes Cell Death in Parkinson's Disease Models by Directly Targeting MEF2D.Neurochem Res. 2021 Feb;46(2):299-308. doi: 10.1007/s11064-020-03166-0. Epub 2020 Nov 12. Neurochem Res. 2021. PMID: 33179210
-
Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons.J Neurosci. 2012 Feb 22;32(8):2790-803. doi: 10.1523/JNEUROSCI.3609-11.2012. J Neurosci. 2012. PMID: 22357862 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous